dockets: CMS-2008-0122

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
CMS-2008-0122 CMS Revisions to the Medicare Advantage and Prescription Drug Benefit Programs Rulemaking 2021-04-21T01:00:55Z 0b00006480732ab2 0938-AP52 This interim final rule with comment period (IFC) revises the regulations governing the Medicare Advantage (MA) program (Part C), prescription drug benefit program (Part D) and section 1876 cost plans. This IFC makes conforming changes to the MA regulations to reflect new statutory requirements regarding special needs plans (SNP), private-fee-for-service plans (PFFS), regional preferred provider organizations (RPPO) plans, Medicare medical savings accounts (MSA) plans, and new statutory provisions governing cost-sharing for dual-eligible enrollees in the MA program prescription drug pricing, coverage, and payment processes in the Part D program. In addition, this IFC sets forth new requirements governing the marketing of Part C and Part D plans which by statute must be in place at a date specified by the Secretary, but no later than November 15, 2008. Both the conforming changes to the regulations to reflect new statutory provisions and the new marketing requirements are based on provisions in the Medicare Improvements for Patients and Providers Act (MIPPA), which became law on July 15, 2008.               {"displayProperties": [], "keywords": null, "modifyDate": "2021-04-21T01:00:55Z", "dkAbstract": "This interim final rule with\r\ncomment period (IFC) revises the\r\nregulations governing the Medicare\r\nAdvantage (MA) program (Part C),\r\nprescription drug benefit program (Part\r\nD) and section 1876 cost plans. This IFC\r\nmakes conforming changes to the MA\r\nregulations to reflect new statutory\r\nrequirements regarding special needs\r\nplans (SNP), private-fee-for-service\r\nplans (PFFS), regional preferred\r\nprovider organizations (RPPO) plans,\r\nMedicare medical savings accounts\r\n(MSA) plans, and new statutory\r\nprovisions governing cost-sharing for\r\ndual-eligible enrollees in the MA\r\nprogram prescription drug pricing,\r\ncoverage, and payment processes in the\r\nPart D program. In addition, this IFC\r\nsets forth new requirements governing\r\nthe marketing of Part C and Part D plans\r\nwhich by statute must be in place at a\r\ndate specified by the Secretary, but no\r\nlater than November 15, 2008. Both the\r\nconforming changes to the regulations to\r\nreflect new statutory provisions and the\r\nnew marketing requirements are based\r\non provisions in the Medicare\r\nImprovements for Patients and\r\nProviders Act (MIPPA), which became\r\nlaw on July 15, 2008.", "agencyId": "CMS", "program": null, "shortTitle": null, "subType2": null, "title": "Revisions to the\r\nMedicare Advantage and Prescription\r\nDrug Benefit Programs", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "0938-AP52", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006480732ab2"} single_get

Links from other tables